Zehnatx
1 known investors
Find your way into Zehnatx
Zehna Therapeutics is an early-stage biotech company developing non-bactericidal small-molecule inhibitors of gut microbial enzymes, with lead compounds targeting CutC lyase to lower TMAO levels. Its work focuses on treating cardiometabolic and chronic diseases, with chronic kidney disease as its lead indication.
Founders & leadership
CV
Camilla V. SimpsonChief Executive Officer
RM
Robert Matunas, PhDHead of CMC and Nonclinical Sciences
MB
Mike Bishop, PhDHead of Early Development and Medicinal Chemistry
Investors · 1
Competitors · 7
by search overlap
Sionnatx19 shared keywordsSionna Therapeutics is a biopharmaceutical company founded in 2019 that develops small-molecule therapies for cystic fibrosis by targeting and stabilizing NBD1, the domain of the CFTR protein where the common ΔF508 mutation occurs. It is advancing a portfolio of NBD1 stabilizers and complementary CFTR modulators intended to be used in combination to normalize CFTR function in CF patients.
Serna Bio10 shared keywordsSerna builds a platform to unlock the transcriptome as a drug target for drug discovery. The company integrates technology and biology to change drug discovery processes.
Syrna Therapeutics9 shared keywordsSyrna Therapeutics is a biotech company developing small-molecule covalent translation inhibitors that bind and modify structured domains in the mRNA of disease-causing proteins to block their expression. It uses a 3D structure-guided drug discovery platform, with lead programs in immunology and neurodegeneration and a broader pipeline spanning metabolic disease and oncology.
ロゴマーク：AIRNA9 shared keywordsAIRNA develops genetic medicines that use ADAR, a naturally occurring human protein, to precisely edit RNA and treat genetic diseases without permanently modifying DNA. The company targets diseases where the underlying genetic mechanism is well-established and difficult to address with existing therapeutic approaches.
Therna9 shared keywordsTherna develops an AI platform that designs and optimizes programmable RNA medicines, including mRNA and antisense oligonucleotide/siRNA therapeutics, using generative AI models informed by proprietary experimental validation data.
Cleveland Clinic8 shared keywordsCleveland Clinic is a multi-specialty medical group practice and hospital system founded in 1921, providing patient care, medical research, and education. It operates facilities in the United States and internationally, with its base in Northeast Ohio.
Doximity8 shared keywordsDoximity is the largest verified network of healthcare professionals in the U.S., connecting physicians, PAs, NPs, pharmacists, and medical students across specialties and care settings. The platform provides mobile-first tools for clinical communication, collaboration, and workflow optimization.
Companies competing with Zehnatx for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Zehnatx do?
- Zehna Therapeutics is an early-stage biotech company developing non-bactericidal small-molecule inhibitors of gut microbial enzymes, with lead compounds targeting CutC lyase to lower TMAO levels. Its work focuses on treating cardiometabolic and chronic diseases, with chronic kidney disease as its lead indication.
- Who are Zehnatx's investors?
- Zehnatx's investors include JobsOhio Ventures.